首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 庞艳莉
2022
CA
Systemic and ovarian inflammation in women with polycystic ovary syndrome
J Reprod Immunol, 10.1016/j.jri.2022.103628
CA
Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development
FRONT ENDOCRINOL, 10.3389/fendo.2022.815968
2021
CA
IL-22 and its interaction with amino acid and glycolipid metabolite in polycystic ovary syndrome (PCOS) patients
Chin Med J, 10.1097/CM9.0000000000001915
CA
Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Metabolites, 10.3390/metabo11120869
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Disruption of adipocyte HIF-1 α improves atherosclerosis through the inhibition of ceramide generation
ACTA PHARM SIN B, 10.1016/j.apsb.2021.10.001
CA
Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
FRONT ENDOCRINOL, 10.3389/fendo.2021.667422
2020
CA
The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome
J Endocr, 10.1530/JOE-19-0589
2019
CA
Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome
Nat Med, 10.1038/s41591-019-0509-0
点击查看热心肠日报解读
2018
CA
Elevated CD14++CD16+ Monocytes in Hyperhomocysteinemia-Associated Insulin Resistance in Polycystic Ovary Syndrome
REPROD SCI, 10.1177/1933719118756772
2017
CA
Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression
Endocrinology, 10.1210/en.2017-00039
2016
FA
Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome
Sci Rep, 10.1038/srep26205
FA
Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis
Oncotarget, 10.18632/oncotarget.9486
FA
Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice
JBC, 10.1074/jbc.M115.702654